RxDoctor Payments Data

Anita Kohli, MD

Neuro-ophthalmology · New Haven, CTNPI 1912273830

Payments from drug & device makers

$11,306in general payments, 2019–2025

Across 36 payments — averaging $314.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$10K
  • AbbVie$485
  • CSL Behring$391
  • Octapharma USA, Inc.$62
  • Alk-abello, Inc$52
  • Boston Scientific$32
  • plus $59 from 3 others

What the payments were for

  • Consulting fees$10,05092%
  • Travel & lodging$1401%
  • Food & beverage$6816%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few neuro-ophthalmology providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$28,717
Medicare patients
110
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acetazolamide ErAcetazolamide15$1,002

Paid to pharmacies, not to this prescriber.

Other neuro-ophthalmology in New Haven

Where these figures come from

Is this you, or does something look wrong? →